venlafaxine
Published research on venlafaxine.

Depression is a prevalent and serious condition in older adults and those with cardiovascular disease. Serotonin reuptake inhibitors (SSRIs) are commonly used to treat depression, but when t…
Read article →Effexor (Venlafaxine) is a medication that was originally approved by the FDA in 1993 for the treatment of major depression. Upon ingestion, Effexor functions as an SNRI (or dual-reuptake in…
Read article →Effexor (Venlafaxine) is a drug that was introduced in 1993 as a pharmaceutical antidepressant by Wyeth; its marketing rights are now owned by Pfizer. Pharmacodynamically, it functions prima…
Read article →Effexor (Venlafaxine) is a SNRI (serotonin-norepinephrine reuptake inhibitor) medication prescribed primarily for the treatment of major depressive disorder. It was initially introduced to t…
Read article →Unless a person is dealing with treatment-resistant depression, it’s relatively uncommon for a person to be taking multiple antidepressants. If a person ends up taking multiple antidepressan…
Read article →Effexor (Venlafaxine) is a common antidepressant medication that is classified as an SNRI. It functions by preventing reuptake of the neurotransmitters serotonin and norepinephrine. It diffe…
Read article →